How effective is Serevent for Bronchiectasis? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 3/5
This is a phase IV clinical study of how effective Serevent (salmeterol xinafoate) is for Bronchiectasis and for what kind of people. The study is created by eHealthMe from 3 Serevent users and is updated continuously.
What is Serevent?
Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,586 Serevent users. Check the latest studies of Serevent.
What is Bronchiectasis?
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection) is found to be associated with 785 drugs and 857 conditions by eHealthMe. Check the latest studies of Bronchiectasis.
3 people are studied for taking Serevent in Bronchiectasis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Serevent effectiveness for Bronchiectasis (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 3
- high: 0
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 3
- high: 0
- very high: 0
Gender of people who take Serevent for Bronchiectasis *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Serevent for Bronchiectasis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 33.33 %
Who find Serevent more effective for Bronchiectasis?
* Approximation only. Some reports may have incomplete information.
Do you take Serevent?
- You can start a phase IV clinical trial to monitor Serevent safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
- Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Serevent (15,586 reports)
Treatments, associated drugs and conditions:
- Bronchiectasis (12,460 reports)
How the study uses the data?
The study is based on salmeterol xinafoate (the active ingredients of Serevent) and Serevent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Silodosin cause Thrombocytopenia Aggravated? - 2 seconds ago
- Could Fluconazole cause Panic Disorder? - 2 seconds ago
- Could Zerit cause Weight Increased? - 2 seconds ago
- Could Oxycodone cause Immunodeficiency? - 6 seconds ago
- Escitalopram and Slurred Speech for Women aged 20-29 - 10 seconds ago
- Escitalopram and Language Impairment for Women aged 20-29 - 10 seconds ago
- Escitalopram and Inability To Speak for Women aged 20-29 - 10 seconds ago
- Escitalopram and Impairment Of Speech for Women aged 20-29 - 11 seconds ago
- Escitalopram and Dysphasia for Women aged 20-29 - 11 seconds ago
- Escitalopram and Dysarthria for Women aged 20-29 - 11 seconds ago